Advanced AI chip designs stress ASML's EUV lithography equipment beyond current manufacturing capabilities, limiting fab capacity for AI accelerators.
ASML's $400 million high-numerical-aperture EUV lithography system is the most expensive tool in commercial chipmaking and increasingly essential for AI accelerator designs. Yet a physical constraint persists: current exposure fields cannot print the largest data center chip designs from NVIDIA and Alphabet in a single shot. Existing EUV systems can still manufacture those chips, but only through workarounds that add cost.
Chipmakers circumvent this limitation through stitching—taking multiple exposures on the same wafer and combining them to form one large design. While functional, stitching adds process steps, overlay complexity, and yield risk on the most expensive silicon in the world. The economic toll is real, quietly eroding fab margins across the industry's most advanced nodes.
The solution exists on paper: larger 12-inch photomasks that would let high-numerical-aperture systems expose bigger chip designs in a single shot while substantially lifting productivity. ASML, Taiwan Semiconductor Manufacturing, and industry partners are developing this format now. But the timeline creates tension. ASML has targeted 2031 for a pilot line using the larger format, with TSMC expecting full readiness around 2033.
That five-to-seven-year window presents a problem. AI accelerator designs are growing toward the reticle limit faster than the mask format can mature. Customers will not pause training-cluster roadmaps to wait, so stitching remains embedded in the process, along with its cost drag. Meanwhile, ASML's near-term capacity is capped by physics and clean-room space. Full-year 2026 plans call for roughly 65 Low NA EUV systems and about 130 DUV immersion systems, with a planned 30% capacity increase for 2027 and another 30% under investigation for 2028.
ASML raised full-year 2026 revenue guidance to EUR 43 billion to EUR 45 billion with gross margin of 54% to 56%. Yet the operating math reveals tension. Q2 2026 revenue rose 21.25% year over year to $10.65 billion, but operating income grew only 10.14% and net income only 9.02%, as capacity ramps consume cash before printing revenue. Sell-side analysts carry an average price target of $2,157.87, though the stock settled at $1,698.30 on September 11, 2026, down 6.17% from August 12 but up 59.52% year to date—suggesting much of the AI capacity story is already priced in.
The bear case runs deeper. ASML cites export control restrictions on system shipments to certain customers, tariff announcements, geopolitical developments, and production capacity constraints. China exemplifies the risk: management said China's 2026 net sales will decline sharply versus the very strong business there in 2024 and 2025, and export limits on the most advanced tools remain a live constraint on where the $400 million machine can ship. There is also structural risk that advanced packaging and chiplets could reduce demand for enormous monolithic dies before the larger-mask solution arrives.
Shares trade at roughly 57 times trailing earnings and about 28 times forward earnings, with a market capitalization near $652 billion. That valuation assumes the fix arrives on schedule. CEO Christophe Fouquet observed that ongoing AI-related investments and continued progress in AI technologies are driving demand for advanced logic and memory chips, further strengthening the semiconductor industry's growth outlook. The demand is genuine, but shipment caps sit between that demand and ASML's income statement. The setup looks balanced: the order book, upgrade business, and installed base support the current valuation, though the specific cure for the $400 million machine's single-exposure limit will not arrive until a 2031 pilot line and around 2033 for full readiness. ASML's next Capital Markets Day on June 10, 2027, will provide the next serious update on the larger-mask roadmap and high-numerical-aperture readiness.